Barely Significant
← all excerpts

Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFβ.

PLoS One · 2013 · PMC3813496 · PMID 24205081

Europe PMCDOI
1
hedged sentence
0.0030
closest p · 0.1× alpha
0.0030
boldest claim

The sentences

highly significantP = 0.003actually significant
Our results indicate that treatment with doxorubicin causes a highly significant decrease in both fibroblast ( P = 0.003) and osteoblast ( P = 0.013) colony forming units and concurrent treatment with 1D11 was able to significantly improved numbers of both CFU-Fs ( P = 0.013 ) and CFU-OBs ( P = 0.013 ) ( Figure 2A, B ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.